Mitral Valve Area Calculator
Calculate mitral valve area quickly with our cardiovascular system tool. Get results based on evidence-based formulas with clear explanations.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Mitral Valve Area Calculator
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser — no data is sent to any server.
Formula: MVA = 220 / PHT (Hatle); MVA = Flow / (37.7 x sqrt(Mean Gradient)) (Gorlin)
Worked example — MVA: 1.22 cm2 (PHT) / 1.25 cm2 (Gorlin) | Severity: Moderate | Mean Gradient: 8 mmHg
Formula
MVA = 220 / PHT (Hatle); MVA = Flow / (37.7 x sqrt(Mean Gradient)) (Gorlin)
The Pressure Half-Time method uses the empirical constant 220 divided by the pressure half-time in milliseconds. The Gorlin formula calculates flow rate as (CO x 1000) / (DFP x HR), then divides by the hydraulic constant 37.7 multiplied by the square root of the mean gradient. Both yield valve area in square centimeters.
Worked Examples
Example 1: Moderate Mitral Stenosis Assessment
Problem:A patient with rheumatic heart disease has a Doppler pressure half-time of 180 ms, mean gradient of 8 mmHg, CO of 4.5 L/min, HR 75, and DFP of 0.45s. Calculate MVA.
Solution:PHT Method: MVA = 220 / PHT = 220 / 180 = 1.22 cm2 Gorlin Formula: Flow = (CO x 1000) / (DFP x HR) = (4500) / (0.45 x 75) = 133.3 mL/s MVA = 133.3 / (37.7 x sqrt(8)) = 133.3 / 106.6 = 1.25 cm2 Both methods indicate moderate mitral stenosis.
Result:MVA: 1.22 cm2 (PHT) / 1.25 cm2 (Gorlin) | Severity: Moderate | Mean Gradient: 8 mmHg
Example 2: Severe Mitral Stenosis Evaluation
Problem:A symptomatic patient has PHT of 280 ms, mean gradient of 15 mmHg, CO of 3.8 L/min, HR 88, DFP 0.38s. Calculate MVA and assess severity.
Solution:PHT Method: MVA = 220 / PHT = 220 / 280 = 0.79 cm2 Gorlin Formula: Flow = (3800) / (0.38 x 88) = 113.6 mL/s MVA = 113.6 / (37.7 x sqrt(15)) = 113.6 / 146.0 = 0.78 cm2 Both methods confirm severe stenosis requiring intervention.
Result:MVA: 0.79 cm2 (PHT) / 0.78 cm2 (Gorlin) | Severity: Severe | Intervention indicated
Frequently Asked Questions
What is mitral valve area and why is it important in cardiac assessment?
Mitral valve area (MVA) refers to the effective orifice area of the mitral valve through which blood flows from the left atrium to the left ventricle during diastole. The normal mitral valve area is 4-6 square centimeters, and stenosis occurs when this area is reduced by scarring, calcification, or commissural fusion. MVA is the primary parameter used to grade the severity of mitral stenosis: mild stenosis is defined as MVA greater than 1.5 square centimeters, moderate as 1.0-1.5, and severe as less than 1.0. Accurate MVA measurement is critical because it directly determines the need for intervention, whether percutaneous mitral balloon commissurotomy or surgical valve replacement. The valve area also correlates with symptoms, pulmonary hypertension severity, and long-term outcomes.
How does the Pressure Half-Time method calculate mitral valve area?
The Pressure Half-Time (PHT) method, developed by Hatle and colleagues, uses Doppler echocardiography to estimate MVA. The pressure half-time is defined as the time required for the transmitral pressure gradient to decrease to half its initial peak value. It is measured from the Doppler E-wave deceleration slope of mitral inflow. The empirical formula MVA = 220/PHT was derived from correlation studies with invasive catheterization data. A PHT of 220 milliseconds corresponds to an MVA of 1.0 square centimeter (severe stenosis), while a PHT of 110 milliseconds corresponds to 2.0 square centimeters (mild stenosis). This method is widely used because it is relatively independent of heart rate and flow conditions, though it can be inaccurate immediately after balloon valvuloplasty or in patients with significant aortic regurgitation.
What is the Gorlin formula and when is it preferred over other methods?
The Gorlin formula calculates valve area using hemodynamic data obtained during cardiac catheterization. The formula is MVA = Flow / (37.7 x square root of mean gradient), where flow is the diastolic mitral flow rate calculated from cardiac output, heart rate, and diastolic filling period. The constant 37.7 is derived from the product of an empirical constant (0.85 for the mitral valve) and the gravitational conversion factor (44.3). The Gorlin formula was considered the gold standard before the advent of modern echocardiography and remains important when echocardiographic measurements are discordant or technically limited. However, it is flow-dependent, meaning that in low cardiac output states, the Gorlin formula may underestimate the true valve area. The Hakki simplified formula (MVA = CO / square root of mean gradient) provides a quick approximation.
What are the main causes of mitral stenosis worldwide?
Rheumatic heart disease remains the most common cause of mitral stenosis globally, accounting for the vast majority of cases especially in developing countries. Rheumatic fever causes inflammation and scarring of the valve leaflets, leading to commissural fusion, leaflet thickening, chordal shortening, and calcification over years to decades. In developed countries where rheumatic fever has become less common, degenerative calcific mitral stenosis in elderly patients is increasingly recognized. Other less common causes include congenital mitral stenosis (parachute mitral valve, supravalvular ring), systemic lupus erythematosus, carcinoid heart disease, and radiation-induced valvulopathy. Mitral annular calcification can also cause functional stenosis in elderly patients. The worldwide burden of rheumatic mitral stenosis remains enormous, with an estimated 33 million people affected globally.
How does mitral stenosis lead to pulmonary hypertension?
Mitral stenosis creates a pressure gradient between the left atrium and left ventricle, causing progressive left atrial pressure elevation. As left atrial pressure rises, it is transmitted retrograde to the pulmonary veins, leading to pulmonary venous hypertension. Initially, this causes pulmonary congestion and dyspnea on exertion. Over time, chronically elevated pulmonary venous pressure triggers reactive vasoconstriction of the pulmonary arterioles (reactive pulmonary hypertension), which further increases pulmonary arterial pressure beyond what passive transmission alone would produce. Eventually, structural remodeling of the pulmonary vasculature occurs, including intimal fibrosis and medial hypertrophy, leading to fixed pulmonary hypertension that may not fully reverse even after successful mitral valve intervention. The degree of pulmonary hypertension correlates with symptom severity and is an important factor in timing intervention.
What is percutaneous mitral balloon commissurotomy and who is a candidate?
Percutaneous mitral balloon commissurotomy (PMBC), also known as balloon mitral valvotomy, is a catheter-based procedure that splits fused mitral valve commissures using an inflatable balloon. The procedure is performed via transseptal puncture, advancing a balloon catheter across the atrial septum and positioning it across the stenotic mitral valve. Inflation of the balloon splits the fused commissures, increasing the effective valve area. Ideal candidates have pliable, non-calcified valves with commissural fusion and no significant mitral regurgitation, assessed using the Wilkins echocardiographic scoring system. Patients with Wilkins scores of 8 or below typically have excellent results, with valve area increases from approximately 1.0 to 2.0 square centimeters. PMBC is the procedure of choice for symptomatic severe mitral stenosis with favorable valve morphology, achieving results comparable to surgical commissurotomy with lower morbidity.
What is the Wilkins score and how does it guide treatment decisions?
The Wilkins score (also called the Massachusetts General Hospital score) is an echocardiographic scoring system that evaluates mitral valve morphology to predict the success of percutaneous balloon commissurotomy. Four characteristics are each scored from 1 (minimal) to 4 (severe): leaflet mobility, leaflet thickening, leaflet calcification, and subvalvular thickening. The total score ranges from 4 to 16. Scores of 8 or below indicate favorable valve morphology with high likelihood of successful PMBC, typically achieving valve areas of 1.8 square centimeters or greater. Scores of 9-11 represent intermediate morphology with reasonable but less predictable results. Scores above 12 indicate unfavorable morphology where surgical intervention is generally preferred. The score helps clinicians weigh the risks and benefits of catheter-based versus surgical approaches for each individual patient.
How do symptoms of mitral stenosis correlate with valve area measurements?
The relationship between mitral valve area and symptoms follows a generally predictable pattern, though individual variation exists. Patients with mild stenosis (MVA greater than 1.5 square centimeters) are typically asymptomatic at rest but may develop dyspnea during vigorous exercise or conditions that increase heart rate. Moderate stenosis (MVA 1.0-1.5 square centimeters) usually causes symptoms with moderate exertion such as climbing stairs or brisk walking, and patients may develop atrial fibrillation. Severe stenosis (MVA less than 1.0 square centimeters) causes symptoms at rest or with minimal activity, including dyspnea, orthopnea, and fatigue. However, symptoms can be precipitated at any valve area by conditions that increase heart rate or cardiac output, such as exercise, pregnancy, fever, anemia, or new-onset atrial fibrillation, because shortened diastolic filling time increases the transmitral gradient.
What role does atrial fibrillation play in mitral stenosis management?
Atrial fibrillation is extremely common in mitral stenosis, occurring in 30-50% of symptomatic patients, and significantly impacts clinical management. The loss of atrial contraction reduces ventricular filling by 15-25%, and rapid ventricular rates shorten the diastolic filling period, dramatically increasing transmitral gradients and precipitating pulmonary edema. Heart rate control is therefore critical, typically achieved with beta-blockers or calcium channel blockers to prolong diastolic filling time. Atrial fibrillation in mitral stenosis also carries a very high risk of thromboembolism, with an annual stroke rate of 5-17% without anticoagulation, making long-term warfarin therapy mandatory regardless of CHA2DS2-VASc score. Left atrial enlargement from chronically elevated pressures promotes atrial fibrillation through electrical and structural remodeling, creating a vicious cycle that accelerates clinical deterioration.
How is mitral stenosis severity assessed during pregnancy?
Pregnancy poses unique challenges in mitral stenosis assessment because the normal hemodynamic changes of pregnancy can unmask or worsen previously compensated stenosis. Pregnancy increases blood volume by 40-50%, heart rate by 10-20 beats per minute, and cardiac output by 30-50%, all of which increase transmitral flow and elevate the gradient across a stenotic valve. Women with moderate to severe mitral stenosis (MVA less than 1.5 square centimeters) are at significant risk for heart failure during pregnancy, particularly in the second and third trimesters when hemodynamic demands peak. Echocardiographic assessment should include serial MVA measurements, mean gradient assessment, and pulmonary artery pressure estimation. Beta-blockers are the mainstay of medical management to control heart rate and prolong diastolic filling time. In refractory cases, PMBC can be safely performed during pregnancy with appropriate lead shielding.
References
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮Aortic Valve Area Calculator
Calculate aortic valve area with inputs, formulas, and instant results.
🧮BSA Calculator - Body Surface Area
Calculate bsacalculator body surface area with inputs, formulas, and instant results.
🧮Addiction Calculator
Calculate addiction with inputs, formulas, and instant results.
🧮Alcohol Unit Calculator
Calculate alcohol unit with inputs, formulas, and instant results.
🧮AUDIT-C Calculator
Calculate audit ccalculator with inputs, formulas, and instant results.
🧮AUDIT Full Questionnaire Calculator
Calculate auditfull questionnaire with inputs, formulas, and instant results.
🧮AUDIT Score Calculator
Calculate audit score with inputs, formulas, and instant results.
🧮CAGE Questionnaire Calculator
Calculate cagequestionnaire with inputs, formulas, and instant results.